Immatics IMTX
NASDAQ IMTX
$7.61 -0.83 (-9.83%)
As of: Oct 2, 2026 · 3:04 PM EDT

Immatics (IMTX) Accumulated Expenses (2023 - 2026)

Updated

Immatics (IMTX) reported Accumulated Expenses of $31.28 million for Q2 2026, up 90.6% from $16.41 million a year earlier.

Analysis

Immatics (IMTX) Accumulated Expenses (2023 - 2026) Analysis & Trends

At the end of FY2025, Immatics posted Accumulated Expenses of $20.89 million, up 82.4% from FY2024.

  • By year, Accumulated Expenses came in at $11.45 million in FY2024 (-39.6%) and $18.97 million in FY2023.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Johnson & Johnson 638.12 Bn 556.64 Bn 17.26 Bn
2 AbbVie 462.60 Bn 435.75 Bn 12.70 Bn
3 Merck 358.70 Bn 313.13 Bn 12.21 Bn
4 Novartis Ag 272.16 Bn 228.03 Bn 11.24 Bn
5 Astrazeneca 250.36 Bn 223.92 Bn 12.86 Bn
6 Amgen 227.87 Bn 183.27 Bn 7.24 Bn
7 Gilead Sciences 184.97 Bn 159.08 Bn 6.22 Bn
8 Pfizer 162.61 Bn 109.56 Bn 10.94 Bn
9 Vertex Pharmaceuticals 132.45 Bn 104.46 Bn 2.84 Bn
10 Immatics 1.18 Bn -861.08 Mn -
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 31.28 Mn
Dec 31, 2025 21.53 Mn
Jun 30, 2025 16.41 Mn
Dec 31, 2024 11.31 Mn
Dec 31, 2023 18.87 Mn
API Access

Immatics Accumulated Expenses API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=accumulated-expenses&ticker=IMTX&period=max&api_key=YOUR_API_KEY